HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dora L W Kwong Selected Research

Dora L W Kwong Research Topics

Disease

40Nasopharyngeal Carcinoma
01/2023 - 05/2002
30Neoplasms (Cancer)
11/2022 - 05/2002
5Carcinoma (Carcinomatosis)
01/2023 - 09/2012
5Esophageal Squamous Cell Carcinoma
11/2022 - 01/2020
5Xerostomia
01/2020 - 12/2003
4Lung Neoplasms (Lung Cancer)
09/2022 - 09/2012
3Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 01/2022
3Neoplasm Metastasis (Metastasis)
01/2020 - 01/2017
3Adenocarcinoma
01/2018 - 01/2018
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2016 - 09/2013
3Medulloblastoma
08/2005 - 04/2003
2Deglutition Disorders (Dysphagia)
01/2020 - 01/2018
2Disease Progression
01/2020 - 04/2015
2Lymphatic Metastasis
02/2015 - 12/2007
2Carotid Artery Diseases
02/2015 - 01/2014
2Colorectal Neoplasms (Colorectal Cancer)
08/2013 - 05/2012
2Esophageal Neoplasms (Esophageal Cancer)
12/2007 - 11/2006
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2007 - 07/2002
1Papillary Thyroid Cancer
01/2022
1Pain (Aches)
01/2020
1Hemorrhage
01/2018
1Epistaxis (Nosebleed)
01/2018
1Exanthema (Rash)
02/2016
1Diarrhea
02/2016
1Prostatic Neoplasms (Prostate Cancer)
01/2016
1Sarcoma (Soft Tissue Sarcoma)
06/2015
1Second Primary Neoplasms (Neoplasms, Second)
06/2015
1Neutropenia
04/2015
1Epstein-Barr Virus Infections
09/2014
1Hypertension (High Blood Pressure)
01/2014
1Hypercholesterolemia
01/2014
1Diabetes Mellitus
01/2014
1AIDS-Related Complex (ARC)
07/2013
1Graves Ophthalmopathy
11/2012
1Vomiting
09/2012
1Nausea
09/2012
1Weight Loss (Weight Reduction)
09/2012
1Human Influenza (Influenza)
04/2010
1Colonic Neoplasms (Colon Cancer)
01/2008
1Carcinogenesis
07/2005
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
04/2005
1Necrosis
04/2005
1Brain Injuries (Brain Injury)
04/2005

Drug/Important Bio-Agent (IBA)

6Cisplatin (Platino)FDA LinkGeneric
01/2022 - 10/2002
4Fluorouracil (Carac)FDA LinkGeneric
11/2020 - 04/2015
4DNA (Deoxyribonucleic Acid)IBA
05/2014 - 10/2004
3IodineIBA
01/2022 - 01/2022
3Biomarkers (Surrogate Marker)IBA
01/2017 - 12/2007
2Capecitabine (Xeloda)FDA Link
01/2020 - 04/2015
2MicroRNAs (MicroRNA)IBA
01/2020 - 01/2008
2ElectrolytesIBA
01/2020 - 04/2015
2Tyrosine Kinase InhibitorsIBA
02/2016 - 09/2013
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
11/2020
1Carboplatin (JM8)FDA LinkGeneric
11/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1camrelizumabIBA
10/2018
1Docetaxel (Taxotere)FDA Link
01/2018
1Cetuximab (Erbitux)FDA Link
01/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2016
1AfatinibIBA
02/2016
1B7-H1 AntigenIBA
01/2016
1Viral AntigensIBA
09/2014
1ErbB Receptors (EGF Receptor)IBA
09/2013
1CytokinesIBA
04/2010
1Laminin ReceptorsIBA
12/2007
1ActininIBA
12/2007
1Protein Isoforms (Isoforms)IBA
07/2005
1squamous cell carcinoma-related antigenIBA
07/2005
1transgelinIBA
07/2005
1ProhibitinsIBA
07/2005
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
07/2005
1ManganeseIBA
07/2005
1Oxidoreductases (Dehydrogenase)IBA
07/2005
1Peptide Elongation Factor Tu (EF-Tu)IBA
07/2005
1Phosphates (Orthophosphate)IBA
07/2005
1Phosphopyruvate Hydratase (Enolase)IBA
07/2005
1Proteins (Proteins, Gene)FDA Link
07/2005
1Superoxide DismutaseIBA
07/2005
1TropomyosinIBA
07/2005
1TubulinIBA
07/2005
1PeroxiredoxinsIBA
07/2005

Therapy/Procedure

40Radiotherapy
01/2023 - 05/2002
12Drug Therapy (Chemotherapy)
01/2023 - 04/2003
10Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020 - 10/2004
9Therapeutics
11/2022 - 05/2012
7Chemoradiotherapy
01/2023 - 07/2004
6Adjuvant Chemotherapy
01/2023 - 07/2004
4Induction Chemotherapy
01/2023 - 02/2017
3Neoadjuvant Therapy
11/2022 - 11/2006
3Cranial Irradiation
04/2005 - 04/2003
2Aftercare (After-Treatment)
09/2011 - 08/2006
1Esophagectomy
11/2022
1Palliative Care (Palliative Therapy)
01/2022
1Brachytherapy
01/2020
1Immunotherapy
09/2014
1Self Administration (Administration, Self)
08/2013
1Conformal Radiotherapy
11/2012
1Salvage Therapy
03/2010
1Craniospinal Irradiation
08/2005